| # | Title | Journal | Year | Citations |
|---|
| 1 | Tumor angiogenesis and vascular normalization: alternative therapeutic targets | Angiogenesis | 2017 | 961 |
| 2 | Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab | Angiogenesis | 2012 | 838 |
| 3 | Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo | Angiogenesis | 2014 | 649 |
| 4 | Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions | Angiogenesis | 2014 | 626 |
| 5 | Retinopathy of prematurity | Angiogenesis | 2007 | 535 |
| 6 | Vascular permeability, vascular hyperpermeability and angiogenesis | Angiogenesis | 2008 | 513 |
| 7 | Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy? | Angiogenesis | 2017 | 482 |
| 8 | Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) | Angiogenesis | 2008 | 457 |
| 9 | Platelets and Granulocytes, in Particular the Neutrophils, Form Important Compartments for Circulating Vascular Endothelial Growth Factor | Angiogenesis | 2003 | 442 |
| 10 | Development of the retinal vasculature | Angiogenesis | 2007 | 438 |
| 11 | Consensus guidelines for the use and interpretation of angiogenesis assays | Angiogenesis | 2018 | 429 |
| 12 | Angiogenesis and chronic inflammation: cause or consequence? | Angiogenesis | 2007 | 411 |
| 13 | Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? | Angiogenesis | 2010 | 408 |
| 14 | The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art | Angiogenesis | 2009 | 387 |
| 15 | The pathogenic role of angiogenesis in rheumatoid arthritis | Angiogenesis | 2015 | 383 |
| 16 | Biological activity of bevacizumab, a humanized anti-VEGF antibody in vitro | Angiogenesis | 2004 | 375 |
| 17 | Vascular endothelial growth factor receptor-1 (VEGFR-1/Flt-1): a dual regulator for angiogenesis | Angiogenesis | 2006 | 364 |
| 18 | The role of the Angiopoietins in vascular morphogenesis | Angiogenesis | 2009 | 347 |
| 19 | The role of vasculature in bone development, regeneration and proper systemic functioning | Angiogenesis | 2017 | 341 |
| 20 | The chicken chorioallantoic membrane model in biology, medicine and bioengineering | Angiogenesis | 2014 | 334 |
| 21 | Withaferin A is a potent inhibitor of angiogenesis | Angiogenesis | 2004 | 321 |
| 22 | Endothelium in vitro: a review of human vascular endothelial cell lines for blood vessel-related research | Angiogenesis | 2001 | 312 |
| 23 | Comparison of three in vitro human 'angiogenesis' assays with capillaries formed in vivo | Angiogenesis | 2001 | 296 |
| 24 | Endoglin in angiogenesis and vascular diseases | Angiogenesis | 2008 | 291 |
| 25 | Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61) | Angiogenesis | 2002 | 290 |
| 26 | An in vitro model of angiogenesis: basic features | Angiogenesis | 1999 | 277 |
| 27 | Human melanoma cells transplanted into zebrafish proliferate, migrate, produce melanin, form masses and stimulate angiogenesis in zebrafish | Angiogenesis | 2006 | 268 |
| 28 | Autocrine Role of Interleukin-8 in Induction of Endothelial Cell Proliferation, Survival, Migration and MMP-2 Production and Angiogenesis | Angiogenesis | 2005 | 251 |
| 29 | Zebrafish angiogenesis: a new model for drug screening | Angiogenesis | 1999 | 248 |
| 30 | Wnt/β-Catenin Signaling Induces Proliferation, Survival and Interleukin-8 in Human Endothelial Cells | Angiogenesis | 2005 | 241 |
| 31 | Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion | Angiogenesis | 2012 | 234 |
| 32 | Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen/fibrin materials | Angiogenesis | 2012 | 231 |
| 33 | Early Contribution of Pericytes to Angiogenic Sprouting and Tube Formation | Angiogenesis | 2003 | 228 |
| 34 | Fibronectins in vascular morphogenesis | Angiogenesis | 2009 | 222 |
| 35 | Cooperation between integrin ανβ3 and VEGFR2 in angiogenesis | Angiogenesis | 2009 | 212 |
| 36 | Microvascular dysfunction in COVID-19: the MYSTIC study | Angiogenesis | 2021 | 211 |
| 37 | New insights into the role of mitochondria in cardiac microvascular ischemia/reperfusion injury | Angiogenesis | 2020 | 210 |
| 38 | Sprouty proteins, masterminds of receptor tyrosine kinase signaling | Angiogenesis | 2008 | 208 |
| 39 | Angiogenic growth factors and hypertension | Angiogenesis | 2004 | 204 |
| 40 | Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients | Angiogenesis | 2020 | 204 |
| 41 | Angiogenesis in pancreatic cancer: current research status and clinical implications | Angiogenesis | 2019 | 194 |
| 42 | VEGF, PF4 and PDGF are elevated in platelets of colorectal cancer patients | Angiogenesis | 2012 | 192 |
| 43 | miRNAs regulate the HIF switch during hypoxia: a novel therapeutic target | Angiogenesis | 2018 | 192 |
| 44 | Heme oxygenase-1 accelerates tumor angiogenesis of human pancreatic cancer | Angiogenesis | 2003 | 191 |
| 45 | Recent advances in endometrial angiogenesis research | Angiogenesis | 2005 | 189 |
| 46 | Intussusceptive angiogenesis and its role in vascular morphogenesis, patterning, and remodeling | Angiogenesis | 2009 | 189 |
| 47 | v 3 and αvβ5 integrin antagonists inhibit angiogenesis in vitro | Angiogenesis | 2003 | 183 |
| 48 | Lactate stimulates angiogenesis and accelerates the healing of superficial and ischemic wounds in mice | Angiogenesis | 2012 | 183 |
| 49 | CD34 marks angiogenic tip cells in human vascular endothelial cell cultures | Angiogenesis | 2012 | 178 |
| 50 | Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer | Angiogenesis | 2020 | 174 |
